Amgen 4Q Revenues: $3.8 billion (flat) 4Q Earnings: $961 million (+15%) FY Revenues: $15.0 billion (+2%) FY Earnings: $4.2 billion (+33%) Comments: Product sales were up 2% to $3.7 billion in the quarter. Sales in the U.S. were up 1%, to $2.9 billion, while international sales increased 4% to $774 million. Foreign exchange negatively impacted sales by $30 million. Aranesp sales were down 15% to $706 million in the quarter and down 14% to $3.1 billion for the year due to a decline...